Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Young

Showing results (131-140 of 208) with videos related to

Pageof 21
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 12, 2009
Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis developmentKahina Boukari, Geri Meduri, Sylvie Brailly-Tabard, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2010
TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humansJacques Young, Jérôme Bouligand, Bruno Francou, et al.
European Journal of Endocrinology|November 4, 2011
High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-upSophie Mauclère-Denost, Sophie Leboulleux, Isabelle Borget, et al.
Molecular and Cellular Endocrinology|May 28, 2013
Expression and characterization of androgen receptor coregulators, SRC-2 and HBO1, during human testis ontogenesis and in androgen signaling deficient patientsLavinia Vija, Geri Meduri, Eva Comperat, et al.
The Journal of Clinical Endocrinology and Metabolism|December 28, 2007
Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutationsSylvie Salenave, Philippe Chanson, Hélène Bry, et al.
The Journal of Clinical Endocrinology and Metabolism|October 10, 2015
Unilateral Adrenalectomy as a First-Line Treatment of Cushing's Syndrome in Patients With Primary Bilateral Macronodular Adrenal HyperplasiaEmmanuelle Debillon, Fritz-Line Velayoudom-Cephise, Sylvie Salenave, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2018
Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of <sup>18</sup>F-Fluorocholine PET/CTSerena Grimaldi, Jacques Young, Peter Kamenicky, et al.
Plos One|October 28, 2011
Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutationsBruno Francou, Jérôme Bouligand, Adela Voican, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 2011
Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndromePeter Kamenický, Céline Droumaguet, Sylvie Salenave, et al.
Human Reproduction (Oxford, England)|May 16, 2017
New mutations in non-syndromic primary ovarian insufficiency patients identified via whole-exome sequencingLiliana Catherine Patiño, Isabelle Beau, Carolina Carlosama, et al.
Pageof 21

Showing results (131-140 of 208) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Endocrinology and Metabolism|March 12, 2009
Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis developmentKahina Boukari, Geri Meduri, Sylvie Brailly-Tabard, et al.
The Journal of Clinical Endocrinology and Metabolism|March 3, 2010
TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humansJacques Young, Jérôme Bouligand, Bruno Francou, et al.
European Journal of Endocrinology|November 4, 2011
High-dose mitotane strategy in adrenocortical carcinoma: prospective analysis of plasma mitotane measurement during the first 3 months of follow-upSophie Mauclère-Denost, Sophie Leboulleux, Isabelle Borget, et al.
Molecular and Cellular Endocrinology|May 28, 2013
Expression and characterization of androgen receptor coregulators, SRC-2 and HBO1, during human testis ontogenesis and in androgen signaling deficient patientsLavinia Vija, Geri Meduri, Eva Comperat, et al.
The Journal of Clinical Endocrinology and Metabolism|December 28, 2007
Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutationsSylvie Salenave, Philippe Chanson, Hélène Bry, et al.
The Journal of Clinical Endocrinology and Metabolism|October 10, 2015
Unilateral Adrenalectomy as a First-Line Treatment of Cushing's Syndrome in Patients With Primary Bilateral Macronodular Adrenal HyperplasiaEmmanuelle Debillon, Fritz-Line Velayoudom-Cephise, Sylvie Salenave, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 23, 2018
Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of <sup>18</sup>F-Fluorocholine PET/CTSerena Grimaldi, Jacques Young, Peter Kamenicky, et al.
Plos One|October 28, 2011
Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutationsBruno Francou, Jérôme Bouligand, Adela Voican, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 2011
Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndromePeter Kamenický, Céline Droumaguet, Sylvie Salenave, et al.
Human Reproduction (Oxford, England)|May 16, 2017
New mutations in non-syndromic primary ovarian insufficiency patients identified via whole-exome sequencingLiliana Catherine Patiño, Isabelle Beau, Carolina Carlosama, et al.
Pageof 21